-
2 weeks ago | 
neurologyadvisor.com | Maria Lopez |María Lopez |María López
The experimental treatment, AXS-12 (reboxetine), compared with placebo, significantly reduces the number of weekly cataplexy attacks and additional symptoms of narcolepsy, according to study results presented at the 2025 American Academy of Neurology (AAN) annual meeting, held from April 5 to 9, 2025, in San Diego, California. Narcolepsy is a chronic neurologic disorder that interferes with the brain’s ability to regulate the body’s sleep-wake cycle.
-
Aug 22, 2024 | 
rheumatologyadvisor.com | Peter Stein |Maria Lopez |María Lopez |María López |Hibah Khaja
Pain Management After TKA: How Can We Limit Opioid Utilization? Benefits of Exercise for the Treatment and Management of Osteoarthritis Impact of Mobility Limitations Due to Osteoarthritis on Mental Health American Academy of Orthopaedic Surgeons Release Updated Guidelines for the Treatment of Hip Osteoarthritis Guidelines for Optimal Timing of Total Joint Arthroplasty for Symptomatic OA and ON: Evidence-Based Insights Clinical Tools Powered by
-
Jul 5, 2024 | 
neurologyadvisor.com | Maria Lopez |María Lopez |María López
Neuroinflammatory biomarkers and amyloid-beta positivity correlated with increased symptoms of anxiety and depression during COVID-19 confinement in individuals, especially women, at risk for Alzheimer disease (AD), according to study findings published in Neurology. Researchers conducted a retrospective, observational study analyzing whether COVID-19 confinement between May 8 and August 31, 2020 in Spain accelerated AD progression in 921 adults by increasing symptoms of anxiety and depression.
-
Jun 7, 2024 | 
ophthalmologyadvisor.com | Maria Lopez |María Lopez |María López
Residential exposure to airborne heavy metals may increase the risk of developing Parkinson disease (PD), according to study results presented at the 2024 American Academy of Neurology (AAN) annual meeting, held from April 13 to 18, 2024, in Denver, Colorado. Exposure to heavy metals through inhalation, ingestion, or skin contact has raised concern for the chronic and potentially irreversible side effect of neurotoxicity.
-
May 28, 2024 | 
psychiatryadvisor.com | Dea Kastrati |Maria Lopez |María Lopez |María López |Jessica Nye |Kristin Della Volpe
Medication Options for Patients with Postpartum Depression Postpartum Depression Among Women Physicians: Could Zuranolone Provide Hope? Brief Peer-Led Evidence-Based Intervention for Postpartum Depression Ketamine and Psilocybin Update in Treatment-Resistant Depression Depression After COVID-19: Identification and Treatment in Primary Care Clinical Tools Powered by
-
May 21, 2024 | 
dermatologyadvisor.com | Maria Lopez |María Lopez |María López
Transgender and gender nonconforming individuals with inflammatory bowel disease (IBD) vs cisgender individuals with IBD are more likely to experience health care disparities despite increased health care utilization, according to study results presented at the Digestive Disease Week (DDW) Annual Meeting, held in Washington, DC, and virtually, from May 18 to 21, 2024.
-
May 20, 2024 | 
infectiousdiseaseadvisor.com | Maria Lopez |María Lopez |María López
Transgender and gender nonconforming individuals with inflammatory bowel disease (IBD) vs cisgender individuals with IBD are more likely to experience health care disparities despite increased health care utilization, according to study results presented at the Digestive Disease Week (DDW) Annual Meeting, held in Washington, DC, and virtually, from May 18 to 21, 2024.
-
Apr 26, 2024 | 
psychiatryadvisor.com | Maria Lopez |María Lopez |María López
ter 1 month of lemborexant treatment, nearly 30% and over 50% of older adults with insomnia disorder and objective short sleep achieved remission and responded to treatment, respectively, according to study results presented at the 2024 American Academy of Neurology (AAN) annual meeting, held from April 13 to 18, 2024, in Denver, Colorado.
-
Apr 25, 2024 | 
psychiatryadvisor.com | Maria Lopez |María Lopez |María López
Residential exposure to airborne heavy metals may increase the risk of developing Parkinson disease (PD), according to study results presented at the 2024 American Academy of Neurology (AAN) annual meeting, held from April 13 to 18, 2024, in Denver, Colorado. Exposure to heavy metals through inhalation, ingestion, or skin contact has raised concern for the chronic and potentially irreversible side effect of neurotoxicity.
-
Apr 22, 2024 | 
brnw.ch | Maria Lopez |María Lopez |María López
Military service prior to amyotrophic lateral sclerosis (ALS) onset is associated with longer survival, according to study results presented at the 2024 American Academy of Neurology (AAN) annual meeting, held from April 13 to 18, 2024, in Denver, Colorado. Although military service has historically been associated with an increased incidence of ALS, the effects of lead exposure on ALS survival have not been parsed from the impact of military service on ALS survival.
